Lexicon Pharmaceuticals Stock Price on February 12, 2024
| LXRX Stock | USD 0.80 0.02 2.44% |
Below is the normalized historical share price chart for Lexicon Pharmaceuticals extending back to April 07, 2000. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Lexicon Pharmaceuticals stands at 0.80, as last reported on the 1st of December, with the highest price reaching 0.82 and the lowest price hitting 0.78 during the day.
If you're considering investing in Lexicon Stock, it is important to understand the factors that can impact its price. Lexicon Pharmaceuticals has Sharpe Ratio of -0.14, which conveys that the firm had a -0.14% return per unit of risk over the last 3 months. Lexicon Pharmaceuticals exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Lexicon Pharmaceuticals' Mean Deviation of 3.69, risk adjusted performance of (0.11), and Standard Deviation of 6.12 to check out the risk estimate we provide.
At this time, Lexicon Pharmaceuticals' Total Stockholder Equity is fairly stable compared to the past year. Common Stock Shares Outstanding is likely to rise to about 232.2 M in 2024, whereas Other Stockholder Equity is likely to drop slightly above 941 M in 2024. . At this time, Lexicon Pharmaceuticals' Price Book Value Ratio is fairly stable compared to the past year. Price To Book Ratio is likely to rise to 5.52 in 2024, whereas Price To Sales Ratio is likely to drop 208.67 in 2024. Lexicon Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 7th of April 2000 | 200 Day MA 1.816 | 50 Day MA 1.463 | Beta 1.244 |
Lexicon |
Sharpe Ratio = -0.1414
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | LXRX |
Estimated Market Risk
| 6.12 actual daily | 54 54% of assets are less volatile |
Expected Return
| -0.87 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.14 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Lexicon Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Lexicon Pharmaceuticals by adding Lexicon Pharmaceuticals to a well-diversified portfolio.
Price Book 1.6275 | Enterprise Value Ebitda (2.58) | Price Sales 55.6445 | Shares Float 182.1 M | Wall Street Target Price 3.6 |
Lexicon Pharmaceuticals Main Headline on 12th of February 2024
Acquisition by Jeffrey Wade of 314320 shares of Lexicon Phar... by Jeffrey Wade
Filed transaction by Lexicon Pharmaceuticals I officer. Grant, award or other acquisition pursuant to Rule 16b-3(d)
Lexicon Pharmaceuticals Valuation on February 12, 2024
It is possible to determine the worth of Lexicon Pharmaceuticals on a given historical date. On February 12, 2024 Lexicon was worth 2.45 at the beginning of the trading date compared to the closed value of 2.92. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Lexicon Pharmaceuticals stock. Still, in general, we apply an absolute valuation method to find Lexicon Pharmaceuticals' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Lexicon Pharmaceuticals where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Lexicon Pharmaceuticals' related companies.
| Open | High | Low | Close | Volume | |
| 2.35 | 2.44 | 2.32 | 2.39 | 3,282,466 | |
02/12/2024 | 2.45 | 2.97 | 2.39 | 2.92 | 9,041,726 |
| 2.79 | 2.99 | 2.67 | 2.93 | 5,870,871 |
| Backtest Lexicon Pharmaceuticals | | | Lexicon Pharmaceuticals History | | | Lexicon Pharmaceuticals Valuation | Previous | Next |
Lexicon Pharmaceuticals Trading Date Momentum on February 12, 2024
| On February 13 2024 Lexicon Pharmaceuticals was traded for 2.93 at the closing time. The top price for the day was 2.99 and the lowest listed price was 2.67 . The trading volume for the day was 5.9 M. The trading history from February 13, 2024 was a factor to the next trading day price jump. The trading delta at closing time against the next closing price was 0.34% . The trading delta at closing time against the current closing price is 10.96% . |
Lexicon Pharmaceuticals Fundamentals Correlations and Trends
By evaluating Lexicon Pharmaceuticals' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Lexicon Pharmaceuticals' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Lexicon financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Lexicon Pharmaceuticals Stock history
Lexicon Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Lexicon is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Lexicon Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Lexicon Pharmaceuticals stock prices may prove useful in developing a viable investing in Lexicon Pharmaceuticals
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 221.1 M | 232.2 M | |
| Net Loss | -117.2 M | -123.1 M |
Lexicon Pharmaceuticals Quarterly Net Working Capital |
|
Lexicon Pharmaceuticals Stock Technical Analysis
Lexicon Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Lexicon Pharmaceuticals Period Price Range
Low | December 1, 2024
| High |
0.00 | 0.00 |
Lexicon Pharmaceuticals cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Lexicon Pharmaceuticals December 1, 2024 Market Strength
Market strength indicators help investors to evaluate how Lexicon Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Lexicon Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Lexicon Pharmaceuticals stock market strength indicators, traders can identify Lexicon Pharmaceuticals entry and exit signals to maximize returns
Lexicon Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Lexicon Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Lexicon Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Lexicon to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.11) | |||
| Jensen Alpha | (1.09) | |||
| Total Risk Alpha | (1.97) | |||
| Treynor Ratio | (0.82) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Lexicon Stock Analysis
When running Lexicon Pharmaceuticals' price analysis, check to measure Lexicon Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lexicon Pharmaceuticals is operating at the current time. Most of Lexicon Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Lexicon Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lexicon Pharmaceuticals' price. Additionally, you may evaluate how the addition of Lexicon Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.